{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:26:08Z","timestamp":1793467568708,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,22]],"date-time":"2024-03-22T00:00:00Z","timestamp":1711065600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.clinre.2024.102322","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T04:59:45Z","timestamp":1710824385000},"page":"102322","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Pathophysiology and management of enteric hyperoxaluria"],"prefix":"10.1016","volume":"48","author":[{"given":"Jordan","family":"Desenclos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentine","family":"Fort\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Daudon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6053-8975","authenticated-orcid":false,"given":"Emmanuel","family":"Letavernier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinre.2024.102322_bib0001","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0168-9452(03)00120-1","article-title":"Advances in our understanding of calcium oxalate crystal formation and function in plants","volume":"164","author":"Nakata","year":"2003","journal-title":"Plant Sci"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0002","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3390\/nu13010062","article-title":"Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion","volume":"13","author":"Crivelli","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0003","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.urology.2014.03.053","article-title":"Oxalate content of food: a tangled web","volume":"84","author":"Attalla","year":"2014","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0004","doi-asserted-by":"crossref","first-page":"F409","DOI":"10.1152\/ajprenal.00373.2018","article-title":"Dietary oxalate and kidney stone formation","volume":"316","author":"Mitchell","year":"2019","journal-title":"Am J Physiol - Ren Physiol"},{"issue":"2","key":"10.1016\/j.clinre.2024.102322_bib0005","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3109\/00365527809181746","article-title":"Evidence for excessive absorption of oxalate by the colon in enteric hyperoxaluria","volume":"13","author":"Modigliani","year":"1978","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.clinre.2024.102322_bib0006","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.semnephrol.2008.01.007","article-title":"The roles and mechanisms of intestinal oxalate transport in oxalate homeostasis","volume":"28","author":"Hatch","year":"2008","journal-title":"Semin Nephrol"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0007","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1002\/cphy.c210013","article-title":"Oxalate flux across the intestine: contributions from membrane transporters","volume":"12","author":"Whittamore","year":"2021","journal-title":"Compr Physiol"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0008","first-page":"341","article-title":"Urinary oxalate, glycolate, glyoxylate, and citrate after acute intravenous administration of glyoxylate in rats","volume":"4","author":"Ogawa","year":"2000","journal-title":"Mol Urol"},{"issue":"6","key":"10.1016\/j.clinre.2024.102322_bib0009","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1681\/ASN.2017040390","article-title":"Hydroxyproline metabolism and oxalate synthesis in primary hyperoxaluria","volume":"29","author":"Fargue","year":"2018","journal-title":"J Am Soc Nephrol JASN"},{"issue":"10","key":"10.1016\/j.clinre.2024.102322_bib0010","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1056\/NEJMicm2113369","article-title":"Primary hyperoxaluria","volume":"386","author":"Xie","year":"2022","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0011","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00240-016-0868-7","article-title":"Ascorbic acid intake and oxalate synthesis","volume":"44","author":"Knight","year":"2016","journal-title":"Urolithiasis"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0012","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1172\/JCI108994","article-title":"Renal tubular transport of organic acids. Studies with oxalate and para-aminohippurate in the rat","volume":"61","author":"Weinman","year":"1978","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.clinre.2024.102322_bib0013","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1097\/01.ASN.0000127864.26968.7F","article-title":"Dependence of oxalate absorption on the daily calcium intake","volume":"15","author":"von Unruh","year":"2004","journal-title":"J Am Soc Nephrol JASN"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0014","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.juro.2013.03.074","article-title":"Dietary calcium from dairy and nondairy sources, and risk of symptomatic kidney stones","volume":"190","author":"Taylor","year":"2013","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.clinre.2024.102322_bib0015","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0016-5085(76)80318-6","article-title":"Effect of bile salts and fatty acids on the colonic absorption of oxalate","volume":"70","author":"Dobbins","year":"1976","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-1097(03)00864-4","article-title":"Oxalobacter formigenes and its role in oxalate metabolism in the human gut","volume":"230","author":"Stewart","year":"2004","journal-title":"FEMS Microbiol Lett"},{"issue":"6","key":"10.1016\/j.clinre.2024.102322_bib0017","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1681\/ASN.2007101058","article-title":"Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones","volume":"19","author":"Kaufman","year":"2008","journal-title":"J Am Soc Nephrol JASN"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0018","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.kint.2019.02.012","article-title":"Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis","volume":"96","author":"Miller","year":"2019","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.clinre.2024.102322_bib0019","first-page":"1464","article-title":"Effects of oxalobacter formigenes in subjects with primary hyperoxaluria Type 1 and end-stage renal disease: a phase II study","volume":"36","author":"Hoppe","year":"2021","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0020","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/sj.ki.5000162","article-title":"Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion","volume":"69","author":"Hatch","year":"2006","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00240-019-01144-y","article-title":"Induction of enteric oxalate secretion by Oxalobacter formigenes in mice does not require the presence of either apical oxalate transport proteins Slc26A3 or Slc26A6","volume":"48","author":"Hatch","year":"2020","journal-title":"Urolithiasis"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0022","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/MNH.0000000000000510","article-title":"The use of antibiotics and risk of kidney stones","volume":"28","author":"Joshi","year":"2019","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"8","key":"10.1016\/j.clinre.2024.102322_bib0023","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1681\/ASN.0000000000000155","article-title":"Outpatient antibiotic use is not associated with an increased risk of first-time symptomatic kidney stones","volume":"34","author":"Thongprayoon","year":"2023","journal-title":"J Am Soc Nephrol JASN"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0024","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/geno.2000.6445","article-title":"Cloning and characterization of SLC26A6, a novel member of the solute carrier 26 gene family","volume":"72","author":"Waldegger","year":"2001","journal-title":"Genomics"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0025","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/ng1762","article-title":"Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6","volume":"38","author":"Jiang","year":"2006","journal-title":"Nat Genet"},{"issue":"11","key":"10.1016\/j.clinre.2024.102322_bib0026","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1136\/jmedgenet-2021-108256","article-title":"Dominant negative mutation in oxalate transporter SLC26A6 associated with enteric hyperoxaluria and nephrolithiasis","volume":"59","author":"Corni\u00e8re","year":"2022","journal-title":"J Med Genet"},{"issue":"6","key":"10.1016\/j.clinre.2024.102322_bib0027","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.ajhg.2016.03.026","article-title":"Mutations in SLC26A1 cause nephrolithiasis","volume":"98","author":"Gee","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0028","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1172\/JCI31474","article-title":"Urolithiasis and hepatotoxicity are linked to the anion transporter Sat1 in mice","volume":"120","author":"Dawson","year":"2010","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0029","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1089\/104454903321112460","article-title":"The mouse sulfate anion transporter gene Sat1 (Slc26a1): cloning, tissue distribution, gene structure, functional characterization, and transcriptional regulation thyroid hormone","volume":"22","author":"Lee","year":"2003","journal-title":"DNA Cell Biol"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0030","doi-asserted-by":"crossref","first-page":"C52","DOI":"10.1152\/ajpcell.00385.2011","article-title":"Sat1 is dispensable for active oxalate secretion in mouse duodenum","volume":"303","author":"Ko","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0031","doi-asserted-by":"crossref","first-page":"G82","DOI":"10.1152\/ajpgi.00299.2018","article-title":"Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia","volume":"316","author":"Whittamore","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"7","key":"10.1016\/j.clinre.2024.102322_bib0032","doi-asserted-by":"crossref","first-page":"G520","DOI":"10.1152\/ajpgi.00167.2013","article-title":"Transcellular oxalate and Cl- absorption in mouse intestine is mediated by the DRA anion exchanger Slc26a3, and DRA deletion decreases urinary oxalate","volume":"305","author":"Freel","year":"2013","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"13","key":"10.1016\/j.clinre.2024.102322_bib0033","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.153359","article-title":"Small-molecule inhibitor of intestinal anion exchanger SLC26A3 for treatment of hyperoxaluria and nephrolithiasis","volume":"7","author":"Cil","year":"2022","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0034","first-page":"454","article-title":"Bacteria, bones, and stones: managing complications of short bowel syndrome","volume":"33","author":"Johnson","year":"2018","journal-title":"Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0035","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.juro.2009.11.022","article-title":"Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery","volume":"183","author":"Maalouf","year":"2010","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.clinre.2024.102322_bib0036","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/00365527809181767","article-title":"Enteric hyperoxaluria: dependence on small intestinal resection, colectomy, and steatorrhoea in chronic inflammatory bowel disease","volume":"13","author":"Hylander","year":"1978","journal-title":"Scand J Gastroenterol"},{"issue":"8","key":"10.1016\/j.clinre.2024.102322_bib0037","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2215\/CJN.00010111","article-title":"Oxalate nephropathy associated with chronic pancreatitis","volume":"6","author":"Cartery","year":"2011","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"18","key":"10.1016\/j.clinre.2024.102322_bib0038","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1001\/jama.2023.19574","article-title":"Risk of gastrointestinal adverse events associated with glucagon-like peptide-1 receptor agonists for weight loss","volume":"330","author":"Sodhi","year":"2023","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.clinre.2024.102322_bib0039","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/archinternmed.2011.103","article-title":"Orlistat and acute kidney injury: an analysis of 953 patients","volume":"171","author":"Weir","year":"2011","journal-title":"Arch Intern Med"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0040","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ki.2014.352","article-title":"Kidney stones are common after bariatric surgery","volume":"87","author":"Lieske","year":"2015","journal-title":"Kidney Int"},{"issue":"11","key":"10.1016\/j.clinre.2024.102322_bib0041","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1038\/ki.2011.287","article-title":"Hyperoxaluria: a gut-kidney axis?","volume":"80","author":"Robijn","year":"2011","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.clinre.2024.102322_bib0042","first-page":"195","article-title":"[Whewellite and weddellite: toward a different etiopathogenesis. The significance of morphological typing of calculi]","volume":"5","author":"Daudon","year":"1984","journal-title":"Nephrologie"},{"issue":"11","key":"10.1016\/j.clinre.2024.102322_bib0043","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.crci.2016.08.009","article-title":"Respective influence of calcium and oxalate urine concentration on the formation of calcium oxalate monohydrate or dihydrate crystals","volume":"19","author":"Daudon","year":"2016","journal-title":"Comptes Rendus Chim"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0044","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.nephro.2015.03.003","article-title":"[Crystalluria]","volume":"11","author":"Daudon","year":"2015","journal-title":"Nephrol Ther"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0045","first-page":"349","article-title":"[Crystalline pathologies in the human body: first steps of pathogenesis]","volume":"78","author":"Bazin","year":"2020","journal-title":"Ann Biol Clin (Paris)"},{"issue":"6","key":"10.1016\/j.clinre.2024.102322_bib0046","doi-asserted-by":"crossref","first-page":"F1123","DOI":"10.1152\/ajprenal.00136.2006","article-title":"Molecular modulation of calcium oxalate crystallization","volume":"291","author":"De Yoreo","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/j.clinre.2024.102322_bib0047","series-title":"StatPearls [Internet]","article-title":"Acute renal colic","author":"Patti","year":"2023"},{"issue":"9","key":"10.1016\/j.clinre.2024.102322_bib0048","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.ekir.2020.06.021","article-title":"Clinical features, and outcome of oxalate nephropathy","volume":"5","author":"Buysschaert","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"5","key":"10.1016\/j.clinre.2024.102322_bib0049","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ki.2013.207","article-title":"NALP3-mediated inflammation is a principal cause of progressive renal failure in oxalate nephropathy","volume":"84","author":"Knauf","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0050","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/MNH.0000000000000229","article-title":"Oxalate, inflammasome, and progression of kidney disease","volume":"25","author":"Ermer","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0051","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1172\/JCI63679","article-title":"Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1\u03b2 secretion","volume":"123","author":"Mulay","year":"2013","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0052","first-page":"507","article-title":"Molecular mechanisms of crystal-related kidney inflammation and injury. Implications for cholesterol embolism, crystalline nephropathies and kidney stone disease","volume":"29","author":"Mulay","year":"2014","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0053","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrneph.2017.10","article-title":"Crystal nephropathies: mechanisms of crystal-induced kidney injury","volume":"13","author":"Mulay","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.clinre.2024.102322_bib0054","article-title":"Circulating oxalate levels in short bowel syndrome as a severity marker of chronic kidney disease","author":"Grocholski","year":"2023","journal-title":"Kidney Int Rep [Internet]."},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00240-020-01217-3","article-title":"Urine and stone analysis for the investigation of the renal stone former: a consensus conference","volume":"49","author":"Williams","year":"2021","journal-title":"Urolithiasis"},{"issue":"7631","key":"10.1016\/j.clinre.2024.102322_bib0056","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/S0140-6736(69)92488-X","article-title":"Urinary creatinine excretion as an index of the copleteness of 24-hour urine collections","volume":"2","author":"Edwards","year":"1969","journal-title":"Lancet Lond Engl"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0057","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12916-015-0275-x","article-title":"New anthropometry-based age- and sex-specific reference values for urinary 24-hour creatinine excretion based on the adult Swiss population","volume":"13","author":"Forni Ogna","year":"2015","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.clinre.2024.102322_bib0058","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.33263\/BRIAC95.305310","article-title":"Analytical procedures and methods validation for oxalate content estimation","volume":"9","author":"Karamad","year":"2019","journal-title":"Biointerface Res Appl Chem"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0059","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0009-8981(82)90364-3","article-title":"The determination of oxalate in urine and urinary calculi by a new ion-chromatographic technique","volume":"126","author":"Robertson","year":"1982","journal-title":"Clin Chim Acta Int J Clin Chem"},{"issue":"12","key":"10.1016\/j.clinre.2024.102322_bib0060","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1093\/clinchem\/25.12.1993","article-title":"Gas-chromatographic estimation of urinary oxalate and its comparison with a colorimetric method","volume":"25","author":"Farrington","year":"1979","journal-title":"Clin Chem"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0061","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0004563217739035","article-title":"A combined liquid chromatography tandem mass spectrometry assay for the quantification of urinary oxalate and citrate in patients with nephrolithiasis","volume":"55","author":"Marshall","year":"2018","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0062","first-page":"379","article-title":"[Clinical value of crystalluria study]","volume":"62","author":"Daudon","year":"2004","journal-title":"Ann Biol Clin (Paris)"},{"issue":"Suppl 2","key":"10.1016\/j.clinre.2024.102322_bib0063","first-page":"s1479","article-title":"Crystalluria","volume":"53","author":"Daudon","year":"2015","journal-title":"Clin Chem Lab Med"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0064","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3390\/healthcare11010002","article-title":"Description of stone morphology and crystalluria improve diagnosis and care of kidney stone formers","volume":"11","author":"Letavernier","year":"2022","journal-title":"Healthcare"},{"issue":"11","key":"10.1016\/j.clinre.2024.102322_bib0065","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.crci.2016.04.010","article-title":"Crystalluria analysis improves significantly etiologic diagnosis and therapeutic monitoring of nephrolithiasis","volume":"19","author":"Daudon","year":"2016","journal-title":"Comptes Rendus Chim"},{"issue":"5","key":"10.1016\/j.clinre.2024.102322_bib0066","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1111\/j.1523-1755.2005.00292.x","article-title":"Serial crystalluria determination and the risk of recurrence in calcium stone formers","volume":"67","author":"Daudon","year":"2005","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.clinre.2024.102322_bib0067","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1053\/j.ajkd.2021.07.018","article-title":"Pathophysiology and management of hyperoxaluria and oxalate nephropathy: a review","volume":"79","author":"Demoulin","year":"2022","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"11","key":"10.1016\/j.clinre.2024.102322_bib0068","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1016\/j.crci.2016.02.004","article-title":"Shedding light on the morphology of calcium oxalate monohydrate crystallites present in kidney biopsies in the case of hyperoxaluria","volume":"19","author":"Bazin","year":"2016","journal-title":"Comptes Rendus Chim"},{"issue":"5","key":"10.1016\/j.clinre.2024.102322_bib0069","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00240-020-01202-w","article-title":"Calcium oxalate crystal deposition in the kidney: identification, causes and consequences","volume":"48","author":"Geraghty","year":"2020","journal-title":"Urolithiasis"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.ajkd.2022.11.016","article-title":"Acute kidney injury and hair-straightening products: a case series","volume":"82","author":"Bnaya","year":"2023","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0071","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1159\/000449128","article-title":"Reversal of gastric bypass resolves hyperoxaluria and improves oxalate nephropathy secondary to roux-en-Y gastric bypass","volume":"6","author":"Agrawal","year":"2016","journal-title":"Case Rep Nephrol Dial"},{"issue":"2","key":"10.1016\/j.clinre.2024.102322_bib0072","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s11894-007-0005-4","article-title":"Pancreatic enzyme therapy for pancreatic exocrine insufficiency","volume":"9","author":"Dom\u00ednguez-Mu\u00f1oz","year":"2007","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0073","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.juro.2008.05.007","article-title":"Urinary stone disease in adults with celiac disease: prevalence, incidence and urinary determinants","volume":"180","author":"Ciacci","year":"2008","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.clinre.2024.102322_bib0074","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.juro.2014.05.006","article-title":"Medical management of kidney stones: AUA guideline","volume":"192","author":"Pearle","year":"2014","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0075","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1056\/NEJM197307262890402","article-title":"Mechanism for hyperoxaluria in patients with ileal dysfunction","volume":"289","author":"Chadwick","year":"1973","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.clinre.2024.102322_bib0076","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.urology.2013.08.002","article-title":"Dietary management of idiopathic hyperoxaluria and the influence of patient characteristics and compliance","volume":"82","author":"Schwen","year":"2013","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0077","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00240-015-0846-5","article-title":"The management of patients with enteric hyperoxaluria","volume":"44","author":"Asplin","year":"2016","journal-title":"Urolithiasis"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0078","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2215\/CJN.08000520","article-title":"Pathophysiology and treatment of enteric hyperoxaluria","volume":"16","author":"Witting","year":"2021","journal-title":"Clin J Am Soc Nephrol CJASN"},{"issue":"11","key":"10.1016\/j.clinre.2024.102322_bib0079","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1038\/sj.ki.5001906","article-title":"Hydroxyproline ingestion and urinary oxalate and glycolate excretion","volume":"70","author":"Knight","year":"2006","journal-title":"Kidney Int"},{"issue":"10","key":"10.1016\/j.clinre.2024.102322_bib0080","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1016\/j.ekir.2020.07.008","article-title":"Oxalate nephropathy caused by excessive vitamin c administration in 2 patients with COVID-19","volume":"5","author":"Fontana","year":"2020","journal-title":"Kidney Int Rep"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0081","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/00365528009181482","article-title":"Calcium treatment of enteric hyperoxaluria after jejunoileal bypass for morbid obesity","volume":"15","author":"Hylander","year":"1980","journal-title":"Scand J Gastroenterol"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0082","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.urology.2008.10.035","article-title":"Effect of dietary changes on urinary oxalate excretion and calcium oxalate supersaturation in patients with hyperoxaluric stone formation","volume":"73","author":"Penniston","year":"2009","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.clinre.2024.102322_bib0083","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.urology.2012.02.052","article-title":"Controlled metabolic diet reduces calcium oxalate supersaturation but not oxalate excretion after bariatric surgery","volume":"80","author":"Pang","year":"2012","journal-title":"Urology"},{"issue":"9","key":"10.1016\/j.clinre.2024.102322_bib0084","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1007\/s11695-009-9850-6","article-title":"Comparison of the absorption of calcium carbonate and calcium citrate after Roux-en-Y gastric bypass","volume":"19","author":"Tondapu","year":"2009","journal-title":"Obes Surg"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0085","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.juro.2007.11.062","article-title":"Use of sevelamer hydrochloride as an oxalate binder","volume":"179","author":"Lieske","year":"2008","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.clinre.2024.102322_bib0086","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/iju5.12296","article-title":"Lanthanum carbonate to control plasma and urinary oxalate level in type 1 primary hyperoxaluria?","volume":"4","author":"Pozdzik","year":"2021","journal-title":"IJU Case Rep"},{"issue":"5","key":"10.1016\/j.clinre.2024.102322_bib0087","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00240-022-01352-z","article-title":"What treatments reduce kidney stone risk in patients with bowel disease?","volume":"50","author":"Bianco","year":"2022","journal-title":"Urolithiasis"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0088","first-page":"193","article-title":"Enteral\u201d hyperoxaluria. Effect of cholestyramine, calcium, neomycin, and bile acids on intestinal oxalate absorption in man","volume":"24","author":"Caspary","year":"1977","journal-title":"Acta Hepatogastroenterol (Stuttg)"},{"issue":"1","key":"10.1016\/j.clinre.2024.102322_bib0089","first-page":"93","article-title":"Effects of calcium, aluminium, magnesium and cholestyramine on hyperoxaluria in patients with jejunoileal bypass","volume":"149","author":"Nordenvall","year":"1983","journal-title":"Acta Chir Scand"},{"issue":"2","key":"10.1016\/j.clinre.2024.102322_bib0090","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000448766","article-title":"A double-blind, placebo controlled, randomized phase 1 cross-over study with ALLN-177, an orally administered oxalate degrading enzyme","volume":"44","author":"Langman","year":"2016","journal-title":"Am J Nephrol"},{"issue":"11","key":"10.1016\/j.clinre.2024.102322_bib0091","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.34067\/KID.0001522020","article-title":"A prospective, double-blind, randomized, placebo-controlled, crossover study using an orally administered oxalate decarboxylase (OxDC)","volume":"1","author":"Quintero","year":"2020","journal-title":"Kidney360"},{"issue":"5","key":"10.1016\/j.clinre.2024.102322_bib0092","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/ndt\/gfaa379","article-title":"Pilot study of reloxaliase in patients with severe enteric hyperoxaluria and hyperoxalemia","volume":"36","author":"Pfau","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.clinre.2024.102322_bib0093","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2100053","article-title":"Randomized placebo-controlled trial of reloxaliase in enteric hyperoxaluria","volume":"1","author":"Lieske","year":"2022","journal-title":"NEJM Evid"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0094","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1681\/ASN.2016020132","article-title":"Oxalobacter formigenes\u2013derived bioactive factors stimulate oxalate transport by intestinal epithelial cells","volume":"28","author":"Arvans","year":"2017","journal-title":"J Am Soc Nephrol JASN"},{"issue":"2","key":"10.1016\/j.clinre.2024.102322_bib0095","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00240-022-01310-9","article-title":"Oxalobacter formigenes treatment confers protective effects in a rat model of primary hyperoxaluria by preventing renal calcium oxalate deposition","volume":"50","author":"Verhulst","year":"2022","journal-title":"Urolithiasis"},{"issue":"5","key":"10.1016\/j.clinre.2024.102322_bib0096","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00467-016-3553-8","article-title":"A randomised phase I\/II trial to evaluate the efficacy and safety of orally administered oxalobacter formigenes to treat primary hyperoxaluria","volume":"32","author":"Hoppe","year":"2017","journal-title":"Pediatr Nephrol Berl Ger"},{"issue":"3","key":"10.1016\/j.clinre.2024.102322_bib0097","doi-asserted-by":"crossref","first-page":"e10539","DOI":"10.15252\/msb.202110539","article-title":"An engineered bacterial therapeutic lowers urinary oxalate in preclinical models and in silico simulations of enteric hyperoxaluria","volume":"18","author":"Lubkowicz","year":"2022","journal-title":"Mol Syst Biol"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124000433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740124000433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T16:54:57Z","timestamp":1714668897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740124000433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":97,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2210740124000433"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102322","relation":{},"ISSN":["2210-7401"],"issn-type":[{"value":"2210-7401","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathophysiology and management of enteric hyperoxaluria","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2024.102322","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"102322"}}